WO2009049961A3 - Nouveaux dérivés d'aspirine donneurs no - Google Patents
Nouveaux dérivés d'aspirine donneurs no Download PDFInfo
- Publication number
- WO2009049961A3 WO2009049961A3 PCT/EP2008/061596 EP2008061596W WO2009049961A3 WO 2009049961 A3 WO2009049961 A3 WO 2009049961A3 EP 2008061596 W EP2008061596 W EP 2008061596W WO 2009049961 A3 WO2009049961 A3 WO 2009049961A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- new
- aspirin derivatives
- donor
- derivatives
- donor aspirin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C203/00—Esters of nitric or nitrous acid
- C07C203/02—Esters of nitric acid
- C07C203/04—Esters of nitric acid having nitrate groups bound to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/08—1,2,5-Oxadiazoles; Hydrogenated 1,2,5-oxadiazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010529313A JP2011500619A (ja) | 2007-10-19 | 2008-09-03 | 新規なno−供与アスピリン誘導体 |
EP08803567A EP2200967A2 (fr) | 2007-10-19 | 2008-09-03 | Nouveaux derives d'aspirine donneurs no |
CA2700243A CA2700243A1 (fr) | 2007-10-19 | 2008-09-03 | Nouveaux derives d'aspirine donneurs no |
US12/679,594 US20100210694A1 (en) | 2007-10-19 | 2008-09-03 | New no-donor aspirin derivatives |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96091207P | 2007-10-19 | 2007-10-19 | |
US60/960,912 | 2007-10-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009049961A2 WO2009049961A2 (fr) | 2009-04-23 |
WO2009049961A3 true WO2009049961A3 (fr) | 2009-06-25 |
Family
ID=40428035
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2008/061596 WO2009049961A2 (fr) | 2007-10-19 | 2008-09-03 | Nouveaux dérivés d'aspirine donneurs no |
Country Status (6)
Country | Link |
---|---|
US (1) | US20100210694A1 (fr) |
EP (1) | EP2200967A2 (fr) |
JP (1) | JP2011500619A (fr) |
AR (1) | AR071638A1 (fr) |
CA (1) | CA2700243A1 (fr) |
WO (1) | WO2009049961A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20111818A1 (it) * | 2011-10-06 | 2013-04-07 | Nicox Sa | Derivati dell'aspirina donatori di ossido nitrico |
CN103687843B (zh) * | 2011-10-24 | 2016-11-16 | 尼科斯科学爱尔兰公司 | 醌基一氧化氮供体化合物 |
CN104350052B (zh) | 2012-05-31 | 2017-05-31 | 施万生物制药研发Ip有限责任公司 | 一氧化氮供体脑啡肽酶抑制剂 |
CN104119289B (zh) * | 2014-07-16 | 2016-08-17 | 成都丽凯手性技术有限公司 | 一种合成氧化呋咱化合物的方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2359110A1 (fr) * | 1976-07-21 | 1978-02-17 | Rohm & Haas | Derives de l'acide salicylique, leur obtention et compositions pharmaceutiques les contenant |
US5859053A (en) * | 1995-05-02 | 1999-01-12 | Bayer Aktiengesellschaft | Acetylsalicylic acid nitrates |
-
2008
- 2008-09-03 EP EP08803567A patent/EP2200967A2/fr not_active Withdrawn
- 2008-09-03 US US12/679,594 patent/US20100210694A1/en not_active Abandoned
- 2008-09-03 WO PCT/EP2008/061596 patent/WO2009049961A2/fr active Application Filing
- 2008-09-03 CA CA2700243A patent/CA2700243A1/fr not_active Abandoned
- 2008-09-03 JP JP2010529313A patent/JP2011500619A/ja active Pending
- 2008-10-17 AR ARP080104556A patent/AR071638A1/es unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2359110A1 (fr) * | 1976-07-21 | 1978-02-17 | Rohm & Haas | Derives de l'acide salicylique, leur obtention et compositions pharmaceutiques les contenant |
US5859053A (en) * | 1995-05-02 | 1999-01-12 | Bayer Aktiengesellschaft | Acetylsalicylic acid nitrates |
Non-Patent Citations (4)
Title |
---|
CHIROLI V ET AL: "Nitric oxide-donating non-steroidal anti-inflammatory drugs: the case of nitroderivatives of aspirin", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, EDITIONS SCIENTIFIQUE ELSEVIER, PARIS, FR, vol. 38, no. 4, 1 April 2003 (2003-04-01), pages 441 - 446, XP004425019, ISSN: 0223-5234 * |
CLARA CENA AND CO, JOURNAL OF MEDICINAL CHEMISTRY, vol. 46, 2003, pages 747 - 754, XP002520872 * |
GILMER ET AL: "Evaluation of nitrate-substituted pseudocholine esters of aspirin as potential nitro-aspirins", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, ELSEVIER SCIENCE, GB, vol. 17, no. 11, 10 May 2007 (2007-05-10), pages 3217 - 3220, XP022068425, ISSN: 0960-894X * |
NIELSEN N M ET AL: "EVALUATION OF GLYCOLAMIDE ESTERS AND VARIOUS OTHER ESTERS OF ASPIRIN AS TRUE ASPIRIN PRODRUGS", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON.; US, vol. 3, no. 32, 1 January 1989 (1989-01-01), pages 727 - 734, XP001076610, ISSN: 0022-2623 * |
Also Published As
Publication number | Publication date |
---|---|
WO2009049961A2 (fr) | 2009-04-23 |
US20100210694A1 (en) | 2010-08-19 |
JP2011500619A (ja) | 2011-01-06 |
CA2700243A1 (fr) | 2009-04-23 |
EP2200967A2 (fr) | 2010-06-30 |
AR071638A1 (es) | 2010-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP2384A (en) | 1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them. | |
WO2009084024A3 (fr) | Procédé pour la préparation de r-sitagliptine et de ses sels pharmaceutiquement acceptables | |
WO2008037716A3 (fr) | Compositions pharmaceutiques | |
WO2007093627A3 (fr) | Composition biocide | |
IL216171A (en) | Lipidic Compound, Method for Preparing the Compound, Pharmaceutical and Lipid Preparations Containing Their Composition and Uses | |
WO2010015657A3 (fr) | Nouveaux alcoxypyrazoles | |
WO2010031720A3 (fr) | Nouvelle formulation d’anticorps | |
IL184562A (en) | Polymorph ivandront a, a process for its preparation and pharmaceutical preparations containing it | |
AP2011005935A0 (en) | New Benzothiadiazepine compounds, a process for their preparation and pharmaceutical compositions comprising them. | |
WO2006134021A3 (fr) | Procede de preparation de nouveaux sels de tiotropium, nouveaux sels de tiotropium en tant que tels et compositions pharmaceutiques associees | |
WO2008129501A3 (fr) | Compositions pharmaceutiques de duloxetine | |
HK1096386A1 (en) | Indanyl-piperazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
WO2009022327A3 (fr) | Nouveau procédé de préparation de lévocétirizine de pureté élevée et de ses sels | |
AP2007004223A0 (en) | Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives | |
WO2010012459A3 (fr) | Procédé de préparation de sels de solifénacine et inclusion de ces derniers dans des formes pharmaceutiques | |
SI2231598T1 (sl) | Novi derivati diazeniumdiolata postopek pripravele teh in njihovi farmacevtski sestavki | |
WO2009051417A3 (fr) | Dérivés de lactame phénanthrène présentant une activité anticancéreuse et procédé de préparation de ceux-ci | |
WO2009049961A3 (fr) | Nouveaux dérivés d'aspirine donneurs no | |
WO2008034912A3 (fr) | Procédé de synthèse du clopidogrel et nouvelles formes de sels pharmaceutiquement acceptables de celui-ci | |
ZA200902414B (en) | Indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them | |
HK1126190A1 (en) | Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them | |
ZA200706067B (en) | Production process for NSAID-containing lozenges, their compositions, their medicinal use | |
ZA200603809B (en) | Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
WO2009013594A3 (fr) | Procédé de préparation de compositions solides à libération contrôlée contenant de l'oxcarbazépine, et compositions obtenues par ce procédé | |
WO2009007747A3 (fr) | Nouveaux composés |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08803567 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2700243 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12679594 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010529313 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008803567 Country of ref document: EP |